论文部分内容阅读
已有报道,低丙种球蛋白血症患者静注丙种球蛋白(以下简称丙球)后可发生非甲非乙型肝炎(NANB 型肝炎)。NANB 型肝炎常可发展为慢性活动性肝炎或肝硬变,而低丙球血症患者发生肝硬变可于5年内死亡。试用类固醇和无环鸟苷治疗输血后肝炎无效。本文作者用人类淋巴母细胞干扰索治疗因低丙球血症输血浆或静注丙球引起的3例慢性 NANB 型肝炎。其中2例为输注丙球所致,在用干扰素治疗前肝功能异常至少
It has been reported that non-A, non-B hepatitis (NANB) may occur after intravenous gamma globulin (hereinafter referred to as C) in patients with low gammaglobulinemia. NANB hepatitis can often develop chronic active hepatitis or cirrhosis, and patients with low plasmapropercrosis cirrhosis can die within 5 years. Trial steroids and acyclovir in the treatment of post-transfusion hepatitis invalid. The authors used human lymphoblastoid cord in the treatment of 3 patients with chronic NANB-type hepatitis caused by plasma or intravenous infusion of corticosteroids in patients with hypo-cessation. Two of them were caused by infusion of corticosteroids, with at least interferon treatment of liver dysfunction before